Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
t-den- f19 (1 trial)
tdenv-f17 (1 trial)
polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)
Dengue (Phase 2)
Fever (Phase 2)
Hemorrhagic Fevers, Viral (Phase 2)
Severe Dengue (Phase 2)
Shock (Phase 2)
Trials (2 total)
Trial APIs (3 total)